Table 15.5b

Steroid Avoidance Rate at Discharge, 1995 to 2004

Recipients of Living Donor Livers

Discharge Regimen Year of Transplant
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Total Patients 41 51 70 71 193 323 448 308 282 287
Steroids Avoided 3 1 3 6 13 30 40 25 63 64
Rate 7.3% 2.0% 4.3% 8.5% 6.7% 9.3% 8.9% 8.1% 22.3% 22.3%
CyA Patients 6 4 11 8 14 16 16 6 9 -
Steroids Avoided 1 0 0 2 4 1 8 1 1 -
Rate 16.7% 0.0% 0.0% 25.0% 28.6% 6.3% 50.0% 16.7% 11.1% -
Tac Patients 12 15 25 27 96 125 156 123 101 105
Steroids Avoided 1 0 2 2 4 7 11 18 27 35
Rate 8.3% 0.0% 8.0% 7.4% 4.2% 5.6% 7.1% 14.6% 26.7% 33.3%
CyA+MMF Patients 5 8 6 6 14 17 22 22 18 17
Steroids Avoided 0 0 0 0 1 0 0 2 2 1
Rate 0.0% 0.0% 0.0% 0.0% 7.1% 0.0% 0.0% 9.1% 11.1% 5.9%
Tac+MMF Patients 2 5 7 24 50 109 171 118 137 138
Steroids Avoided 0 0 0 1 3 5 2 3 28 24
Rate 0.0% 0.0% 0.0% 4.2% 6.0% 4.6% 1.2% 2.5% 20.4% 17.4%
CyA+Aza Patients 8 12 11 1 3 3 2 4 3 2
Steroids Avoided 0 0 0 0 0 0 0 0 1 0
Rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 33.3% 0.0%
Tac+Aza Patients 4 3 2 - 4 2 - 3 - -
Steroids Avoided 0 0 0 - 0 0 - 0 - -
Rate 0.0% 0.0% 0.0% - 0.0% 0.0% - 0.0% - -
Siro+MMF Patients - - - - - 1 5 2 1 1
Steroids Avoided - - - - - 0 0 0 0 0
Rate - - - - - 0.0% 0.0% 0.0% 0.0% 0.0%
CyA+Siro Patients - - - - - 7 6 1 - 1
Steroids Avoided - - - - - 4 3 0 - 0
Rate - - - - - 57.1% 50.0% 0.0% - 0.0%
Tac+Siro Patients - - - - - 20 36 11 1 4
Steroids Avoided - - - - - 8 11 0 0 1
Rate - - - - - 40.0% 30.6% 0.0% 0.0% 25.0%
Other Regimen Patients 4 4 8 5 12 23 34 18 12 19
Steroids Avoided 1 1 1 1 1 5 5 1 4 3
Rate 25.0% 25.0% 12.5% 20.0% 8.3% 21.7% 14.7% 5.6% 33.3% 15.8%


Source: OPTN/SRTR Data as of May 2, 2005.

Includes patients receiving first transplants of any organ with a functioning graft at discharge and any immunosuppressivedrug use recorded at discharge.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine;Siro: Sirolimus.